Skip to content
Disclosery

TAKEDA PHARMACEUTICAL CO LTD

Follow

13F filer, CIK 1395064, Tokyo, Japan

TAKEDA PHARMACEUTICAL CO LTD reported $16,369,175 across 8 holdings for the quarter ended 2025-09-30, in a 13F-HR filed 2025-11-13.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001395064-25-000157

Period
2025-09-30
Reported value
$16.4M
Holdings
8
Top 10 weight
100%
New
0
Sold out
3

Largest buys vs the previous quarter

SecurityShares changeApprox. value
LYELL IMMUNOPHARMA INCadded+13,722$223K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
HILLEVAX INCexited-6,724,000-$13.4M
TURNSTONE BIOLOGICS CORPexited-895,824-$322K
THRDexited-36,835-$200K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2025

Share positions as resolved from 13F-HR 0001395064-25-000157, largest first. % of portfolio is the value over $16,369,175, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
OVIDOVID THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: 7,531,996 shares; 2024Q1: 7,531,996 shares; 2024Q2: 7,531,996 shares; 2024Q3: 7,531,996 shares; 2024Q4: 7,531,996 shares; 2025Q1: 7,531,996 shares; 2025Q2: 7,531,996 shares; 2025Q3: 7,531,996 shares 7,531,996$9.79M59.82%0Timeline
EQEQUILLIUM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: 1,824,977 shares; 2024Q1: 1,824,977 shares; 2024Q2: 1,824,977 shares; 2024Q3: 1,824,977 shares; 2024Q4: 1,824,977 shares; 2025Q1: 1,824,977 shares; 2025Q2: 1,824,977 shares; 2025Q3: 1,824,977 shares 1,824,977$2.61M15.94%0Timeline
XLOXilio Therapeutics Inc.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: 1,475,121 shares; 2024Q1: 1,475,121 shares; 2024Q2: 1,475,121 shares; 2024Q3: 1,475,121 shares; 2024Q4: 1,475,121 shares; 2025Q1: 1,475,121 shares; 2025Q2: 1,475,121 shares; 2025Q3: 1,475,121 shares 1,475,121$1.24M7.59%0Timeline
STTKSHATTUCK LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: 2,090,858 shares; 2024Q1: 1,501,061 shares; 2024Q2: 515,619 shares; 2024Q3: 515,619 shares; 2024Q4: 515,619 shares; 2025Q1: 515,619 shares; 2025Q2: 515,619 shares; 2025Q3: 515,619 shares 515,619$1.23M7.53%0Timeline
LYELL IMMUNOPHARMA INCLYELL IMMUNOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: not reported; 2024Q4: 823,317 shares; 2025Q1: 823,317 shares; 2025Q2: 41,165 shares; 2025Q3: 54,887 shares 54,887$891K5.45%+13,722
AMWLAMERICAN WELL CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: 1,554,669 shares; 2024Q1: 1,554,669 shares; 2024Q2: 1,554,669 shares; 2024Q3: 77,733 shares; 2024Q4: 77,733 shares; 2025Q1: 77,733 shares; 2025Q2: 77,733 shares; 2025Q3: 77,733 shares 77,733$478K2.92%0Timeline
RANIRANI THERAPEUTICS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: 338,679 shares; 2024Q1: 338,679 shares; 2024Q2: 215,172 shares; 2024Q3: 203,190 shares; 2024Q4: 203,190 shares; 2025Q1: 203,190 shares; 2025Q2: 203,190 shares; 2025Q3: 203,190 shares 203,190$102K0.62%0Timeline
LABSTANDARD BIOTOOLS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: 16,515 shares; 2024Q1: 16,515 shares; 2024Q2: 16,515 shares; 2024Q3: 16,515 shares; 2024Q4: 16,515 shares; 2025Q1: 16,515 shares; 2025Q2: 16,515 shares; 2025Q3: 16,515 shares 16,515$21.5K0.13%0Timeline

Sold out in Q3 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
HILLEVAX INCHILLEVAX INC6,724,000$13.4Mshares
TURNSTONE BIOLOGICS CORPTURNSTONE BIOLOGICS CORP895,824$322Kshares
THRDTHIRD HARMONIC BIO INC36,835$200Kshares

How Q3 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001395064-25-000157 base2025-11-13acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001395064-25-000157 Quarter ended 2025-09-302025-11-13acceptance time not in the bulk data set
13F-HR 0001395064-25-000124 Quarter ended 2025-06-302025-08-08acceptance time not in the bulk data set
13F-HR 0001395064-25-000055 Quarter ended 2025-03-312025-05-12acceptance time not in the bulk data set
13F-HR 0001395064-25-000024 Quarter ended 2023-12-312025-02-13acceptance time not in the bulk data set
13F-HR 0001395064-25-000028 Quarter ended 2024-06-302025-02-13acceptance time not in the bulk data set
13F-HR 0001395064-25-000030 Quarter ended 2024-09-302025-02-13acceptance time not in the bulk data set
13F-HR 0001395064-25-000026 Quarter ended 2024-03-312025-02-13acceptance time not in the bulk data set
13F-HR 0001395064-25-000019 Quarter ended 2024-12-312025-02-12acceptance time not in the bulk data set